Semaglutide NAION Risk: EMA Review Initiated Am...

By João L. Carapinha

January 21, 2025

The European Medicines Agency's (EMA) Pharmacovigilance Risk Assessment Committee (PRAC) is reviewing the potent...
Advancing EU Health Technology Assessment: Insights from the HAG Meeting
Cost-Effectiveness of Switching to the Nonavalent HPV Vaccine in the Netherlands
Reevaluating NICE’s Cost-Effectiveness Thresholds: The QALY Debate
AI Tool Predicts Type 2 Diabetes Risk via ECG Up to 10 Years Early
Zepbound Outperforms Wegovy in Weight Loss Trial
Strengthening EU Health Competitiveness: MedTech Europe’s Call for Stra...
Boosting Biopharma SMEs in Europe
Urgent Call for Universal Diabetes Care in Europe Amidst Political Apathy
NICE’s Position on AI in Evidence Generation
Diabetes Crisis in Europe: Urgent Public Health and Economic Challenge
Chancellor Announces £50 Million Boost for UK Medicines Manufacturing
Healthcare for Older Adults in Türkiye: A Call for Reform